ReviewBMC medical research methodology2026
Balancing rigor and pragmatism in health research: a guide to choosing study designs for real-world settings.
Review in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHealth research has traditionally privileged highly controlled study designs to maximise internal validity, yet such approaches often struggle to inform decision-making in complex, real-world settings such as health systems, public health programmes, and low- and middle-income countries. Increasingly, researchers and policy makers require evidence that is not only methodologically sound but also feasible, generalisable, and responsive to contextual constraints. This has intensified debate around how best to balance scientific rigor with pragmatic relevance in study design selection.
aimThis review aimed to provide a practical, design-oriented guide to selecting appropriate study designs for real-world health research by clarifying how rigor and pragmatism can be balanced without compromising methodological integrity.
methodsA narrative methodological approach was conducted, synthesising peer-reviewed and grey literature on study design selection, pragmatic trials, implementation research, and real-world evidence. Searches were undertaken in MEDLINE, Scopus, and Web of Science, alongside guidance from major health research institutions. Evidence was analysed thematically, with study designs compared according to rigor, feasibility, transferability, and ethical and operational considerations.
resultsThe review demonstrates that study designs occupy positions along a rigor-pragmatism continuum rather than discrete methodological hierarchies. Highly controlled designs offer strong causal inference but limited applicability, while pragmatic, hybrid, and observational designs enhance relevance and policy utility when rigorously applied. Contextual factors including health system capacity, ethical feasibility, resource availability, population vulnerability, and implementation stage emerge as critical drivers of appropriate design choice.
conclusionBalancing rigor and pragmatism through context-sensitive design selection can generate more usable evidence, strengthen policy impact, and improve population health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.